Skip to Content

Brooks Laboratories Ltd BROOKS

Morningstar Rating
INR 100.75 +1.95 (1.97%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BROOKS is trading at a 47% discount.
Price
INR 98.06
Fair Value
INR 736.15
Uncertainty
Extreme
1-Star Price
INR 283.68
5-Star Price
INR 84.43
Economic Moat
Fmck
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BROOKS is a good fit for your portfolio.

Trading Information

Previous Close Price
INR 98.80
Day Range
INR 98.80100.75
52-Week Range
INR 56.95179.95
Bid/Ask
INR 100.75 / INR 100.75
Market Cap
INR 2.64 Bil
Volume/Avg
10,959 / 59,244

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.53
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
296

Valuation

Metric
BROOKS
Price/Earnings (Normalized)
Price/Book Value
3.34
Price/Sales
3.53
Price/Cash Flow
Price/Earnings
BROOKS

Financial Strength

Metric
BROOKS
Quick Ratio
0.69
Current Ratio
1.25
Interest Coverage
−26.31
Quick Ratio
BROOKS

Profitability

Metric
BROOKS
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
BROOKS
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AKbnnzfhvSsyx$70.0 Bil
MKKGY
Merck KGaA ADRPzrrhyfltnJwfvg$67.6 Bil
HLN
Haleon PLC ADRXtkbjyvZdpk$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRBmfybtdyxHjfz$14.3 Bil
VTRS
Viatris IncTqhhhrxwjMrj$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRFdvlrbjpbZtdp$11.9 Bil
CTLT
Catalent IncBtwljtzVwdnl$10.0 Bil
PRGO
Perrigo Co PLCLzslyhlrXvbgl$4.1 Bil
CURLF
Curaleaf Holdings IncStpkwrttRqzn$3.6 Bil
PBH
Prestige Consumer Healthcare IncSpsxbrnrVgcndb$3.4 Bil

Sponsor Center